Position in GSK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,299,508
+$1,973,638 QoQ
Shares Held
43,867
+560.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#234
of 1,033 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diversify Advisory Services, LLC holds $87,794,871 across 13 Drug Manufacturers - General names. GSK ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
94,734 | $24,059,593 | |
| 2 | LLY |
ELI LILLY & Co
|
16,684 | $20,011,291 | |
| 3 | ABBV |
AbbVie Inc.
|
64,821 | $16,311,556 | |
| 4 | AMGN |
Amgen Inc
|
22,302 | $8,076,000 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,135 | $3,743,847 | |
| 6 | NVS |
Novartis AG
|
20,054 | $3,142,862 | |
| 7 | PFE |
Pfizer Inc
|
117,466 | $2,828,581 | |
| 8 | GSK |
GSK plc
This page
|
43,867 | $2,299,508 |
All Filings in GSK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,299,508 | 43,867 | Shares | Sole | 2026-08-10 | |
| 2025-12-31 | $325,870 | 6,645 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $292,667 | 6,781 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||